Vascular attack by 5,6-dimethylxanthenone-4-acetic acid combined with B7.1 (CD80)-mediated immunotherapy overcomes immune resistance and leads to the eradication of large tumors and multiple tumor foci

Cancer Research

Volumn 61, Issue 5, 2001, Pages 1948-1956

  Kanwar, Jagat R ^a   Kanwar, Rupinder K ^a   Pandey, Sushil ^a   Ching, Lai Ming ^b   Krissansen, Geoffrey W ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

5,6 DIMETHYLXANTHENONE 4 ACETIC ACID; B7 ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CANCER IMMUNOTHERAPY; CELL PROLIFERATION; CELLULAR IMMUNITY; CONTROLLED STUDY; GENE TRANSFER; MOUSE; MULTIPLE CANCER; NONHUMAN; PRIORITY JOURNAL; RECEPTOR DOWN REGULATION; T LYMPHOCYTE ACTIVATION; TUMOR GROWTH; TUMOR VASCULARIZATION; VASCULAR ENDOTHELIUM; WOUND HEALING;

ANIMALS; ANTIGENS, CD80; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; COMBINED MODALITY THERAPY; FEMALE; FLAVONOIDS; GENE DOSAGE; GENE THERAPY; GENETIC VECTORS; IMMUNOTHERAPY; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; LYMPHOMA; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PATHOLOGIC; T-LYMPHOCYTES, CYTOTOXIC; THYMUS NEOPLASMS; XANTHENES; XANTHONES;

EID: 0035266136     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Taking lessons from dendritic cells: Multiple xenogeneic ligands for leukocyte integrins have the potential to stimulate antitumor immunity
2. Impediments to successful immunotherapy
3. Angiogenesis inhibitors overcome tumor induced endothelial cell anergy
4. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth
5. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
6. Activity of flavone acetic acid (NSC-347512) against solid tumors of mice
7. Pleiotropic resistance and drug development
8. Therapeutic and pharmacokinetic relationships of flavone acetic acid: An agent with activity against solid tumors
9. Flavone acetic acid: A novel agent with preclinical antitumor activity against colon adenocarcinoma 38 in mice
10. Flavone acetic acid-from laboratory to clinic and back
11. Tumor rejection after direct costimulation of CD8+ T cells by B7 transfected melanoma cells
12. Costimulation of antitumor immunity by the B7 counterreceptor for the T lymphocyte molecules CD28 and CTLA-4
13. Constitutive expression of B7 restores immunogenicity of tumor cells expressing truncated MHC class II molecules
14. Immunomodulatory actions of xanthenone anti-cancer agents
15. Cloning of B7.2: A CTLA-4 counter-receptor that costimulates human T cell proliferation
16. Cloning of the mucosal addressin MAdCAM-1 from human brain: Identification of novel alternatively spliced transcripts
17. Serotonin involvement in the antitumor and host effects of flavone-8-acetic acid and 5,6-dimethylxanthenone-4-acetic acid
18. Ablation of colorectal xenografts with combined radioimmunotherapy and tumor blood flow-modifying agents
19. Resistance of cultured Lewis lung carcinoma cell lines to tiazofurin
20. Induction of natural killer cell activity by the antitumor compound flavone acetic acid (NSC 347 512)
21. Effect of flavone acetic acid (NSC 347,512) on splenic cytotoxic effector cells and their role in tumor necrosis
22. Increased plasma serotonin following treatment with flavone-8-acetic acid. 5,6-dimethylxanthenone-4-acetic acid, vinblastine, and colchicine: Relation to vascular effects
23. Evidence for the production of nitric oxide by activated macrophages treated with the antitumor agents flavone-8-acetic acid and xanthenone-4-acetic acid
24. Enhancement of in vitro cytotoxicity of mouse peritoneal exudate cells by flavone acetic acid (NSC 347512)
25. Role of tumor necrosis factor in flavone acetic acid-induced tumor vasculature shutdown
26. Induction of tumor necrosis factor-α messenger RNA in human and murine cells by the flavone acetic acid analogue 5,6-dimethylxanthenone-4-acetic acid (NSC 640488)
27. Induction of intratumoral tumor necrosis factor (TNF) synthesis and hemorrhagic necrosis by 5,6-dimethylxanthenone-4-acetic acid (DMXAA) in TNF knockout mice
28. Evidence for the involvement of endothelial cell integrin αVβ3 in the disruption of the tumor vasculature induced by TNF and IFN-γ
29. Antitumor responses to flavone-8-acetic and 5,6-dimethylxanthenone-4-acetic acid in immune deficient mice
30. Antitumor activity of flavone acetic acid (NSC 347512) in mice-influence of immune status
31. Role of T cells and tumor necrosis factor in antitumor activity and toxicity of flavone acetic acid
32. Tumor immunogenicity is determined by the mechanism of cell death via induction of heat shock protein expression
33. Heat shock protein 70 induced during tumor cell killing induces Th1 cytokines and targets immature dendritic cell precursors to enhance antigen uptake
34. Involvement of CD28 in MHC-unrestricted cytotoxicity mediated by a human natural killer leukemia cell line